A Plasmodium Cross-Stage Antigen Contributes to the Development of Experimental Cerebral Malaria

Area of Science:

• Immunology
• Infectious Diseases
• Neuroscience

Background:

• Cerebral malaria (CM) is a severe neurological complication of Plasmodium falciparum infection, primarily linked to blood-stage parasite interactions.
• The pre-erythrocytic and intra-hepatic stages of malaria parasites are typically considered clinically silent and not implicated in CM development.

Purpose of the Study:

• To investigate the role of the antigen PbmaLS_05, presented during multiple parasite life stages, in the pathogenesis of experimental cerebral malaria (ECM).
• To explore the differential contribution of host immune responses to ECM following infection via sporozoites versus infected red blood cells (iRBCs).

Main Methods:

• Generation and analysis of mice lacking the endogenous PbmaLS_05 antigen.
• Comparative assessment of ECM development and host immune responses after infection with sporozoites or iRBCs.
• Characterization of PbmaLS_05-specific CD8+ T cell responses.

Main Results:

• Deletion of PbmaLS_05 abrogated ECM development in susceptible mice, regardless of infection route (sporozoite or iRBC).
• Significant differences were observed in the host immune response contribution between sporozoite and iRBC infection models.
• PbmaLS_05-specific CD8+ T cells were crucial for ECM development after sporozoite infection but not iRBC infection.

Conclusions:

• The antigen PbmaLS_05 plays a critical role in ECM development, highlighting the importance of parasite stages beyond the blood stage.
• Pre-erythrocytic stage antigens can contribute to cerebral malaria, challenging previous assumptions.
• Understanding the route of infection is vital for developing effective malaria vaccines and therapeutics targeting CM.